Skip to main content
Top
Published in: Cancer Causes & Control 2/2020

01-02-2020 | Lung Cancer | Original Paper

The preventive role of cardiorespiratory fitness in current male smokers who meet the American Cancer Society criteria for lung cancer screening: a prospective pilot study

Authors: Baruch Vainshelboim, Jonathan Myers

Published in: Cancer Causes & Control | Issue 2/2020

Login to get access

Abstract

Purpose

Survival benefits could be potentially improved by adding cardiorespiratory fitness (CRF) to lung cancer screening. The current pilot study aimed to assess the association between CRF and adverse outcomes in current male smokers who are meeting the American Cancer Society (ACS) criteria for lung cancer screening.

Methods

A total of 260 men with a baseline CRF assessment (treadmill exercise test) who are met the ACS lung cancer screening criteria (“current smokers aged 55–74 years with ≥ 30 pack/years smoking history”) were prospectively studied. Cox proportional hazard models were analyzed for all-cause and cancer mortality, total and lung cancer incidence.

Results

Mean age was 63.3 ± 5.4 years, smoking history 50.4 ± 26.7 pack/years, and CRF was 7.8 ± 3.2 metabolic equivalents (METs). During a mean of 10.2 ± 6.1 years follow-up, 80 participants developed any type of cancer, 19 were diagnosed with lung cancer and 66 died (cancer, n = 39, other causes, n = 27). In multivariable models, only CRF was associated with all-cause and cancer mortality. Each 1-MET higher CRF was associated with a 10% reduced risk for all-cause mortality [0.9, 95% CI (0.83 to 0.98), p = 0.017] and cancer mortality [0.9, 95% CI (0.8 to 0.99), p = 0.048]. CRF was not associated with total cancer incidence (p = 0.59) or lung cancer incidence (p = 0.96).

Conclusion

Higher CRF is independently associated with lower risk of all-cause and cancer mortality in current male smokers who meet the ACS criteria for lung cancer screening. Screening for CRF and achieving higher CRF levels could potentially reduce mortality and serve as complementary preventive strategy in heavy smokers.
Literature
1.
go back to reference World Health Organization (2017) WHO report on the global tobacco epidemic, 2017: monitoring tobacco use and prevention policies. World Health Organization, Geneva, p 2017 World Health Organization (2017) WHO report on the global tobacco epidemic, 2017: monitoring tobacco use and prevention policies. World Health Organization, Geneva, p 2017
2.
go back to reference U.S. Department of Health and Human Services (2014) The health consequences of smoking—50 years of progress: a report of the surgeon general U.S. Department of Health and Human Services (2014) The health consequences of smoking—50 years of progress: a report of the surgeon general
3.
go back to reference Islami F, Goding Sauer A, Miller KD, Siegel RL, Fedewa SA, Jacobs EJ, McCullough ML, Patel AV, Ma J, Soerjomataram I, Flanders WD, Brawley OW, Gapstur SM, Jemal A (2017) Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin. https://doi.org/10.3322/caac.21440 CrossRefPubMed Islami F, Goding Sauer A, Miller KD, Siegel RL, Fedewa SA, Jacobs EJ, McCullough ML, Patel AV, Ma J, Soerjomataram I, Flanders WD, Brawley OW, Gapstur SM, Jemal A (2017) Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin. https://​doi.​org/​10.​3322/​caac.​21440 CrossRefPubMed
4.
go back to reference American Cancer Society (2017) Cancer prevention & early detection facts & figures 2017–2018. American Cancer Society, Atlanta American Cancer Society (2017) Cancer prevention & early detection facts & figures 2017–2018. American Cancer Society, Atlanta
5.
go back to reference American Cancer Society (2019) Cancer facts & figures 2019. American Cancer Society, Atlanta American Cancer Society (2019) Cancer facts & figures 2019. American Cancer Society, Atlanta
8.
go back to reference World Health Organization (2014) World cancer report 2014. International Agency for Research on Cancer, Lyon, p 2014CrossRef World Health Organization (2014) World cancer report 2014. International Agency for Research on Cancer, Lyon, p 2014CrossRef
9.
go back to reference National Lung Screening Trial Research T, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365(5):395–409. https://doi.org/10.1056/NEJMoa1102873 CrossRef National Lung Screening Trial Research T, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365(5):395–409. https://​doi.​org/​10.​1056/​NEJMoa1102873 CrossRef
10.
go back to reference Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram-Baptiste D, Saslow D, Brawley OW, Wender RC (2018) Cancer screening in the United States, 2018: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 68(4):297–316. https://doi.org/10.3322/caac.21446 CrossRefPubMed Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram-Baptiste D, Saslow D, Brawley OW, Wender RC (2018) Cancer screening in the United States, 2018: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 68(4):297–316. https://​doi.​org/​10.​3322/​caac.​21446 CrossRefPubMed
12.
go back to reference Ross R, Blair SN, Arena R, Church TS, Despres JP, Franklin BA, Haskell WL, Kaminsky LA, Levine BD, Lavie CJ, Myers J, Niebauer J, Sallis R, Sawada SS, Sui X, Wisloff U, American Heart Association Physical Activity Committee of the Council on L, Cardiometabolic H, Council on Clinical C, Council on E, Prevention, Council on C, Stroke N, Council on Functional G, Translational B, Stroke C (2016) Importance of assessing cardiorespiratory fitness in clinical practice: a case for fitness as a clinical vital sign: a Scientific Statement From the American Heart Association. Circulation 134(24):e653–e699. https://doi.org/10.1161/CIR.0000000000000461 CrossRefPubMed Ross R, Blair SN, Arena R, Church TS, Despres JP, Franklin BA, Haskell WL, Kaminsky LA, Levine BD, Lavie CJ, Myers J, Niebauer J, Sallis R, Sawada SS, Sui X, Wisloff U, American Heart Association Physical Activity Committee of the Council on L, Cardiometabolic H, Council on Clinical C, Council on E, Prevention, Council on C, Stroke N, Council on Functional G, Translational B, Stroke C (2016) Importance of assessing cardiorespiratory fitness in clinical practice: a case for fitness as a clinical vital sign: a Scientific Statement From the American Heart Association. Circulation 134(24):e653–e699. https://​doi.​org/​10.​1161/​CIR.​0000000000000461​ CrossRefPubMed
13.
go back to reference Lee CD, Blair SN (2002) Cardiorespiratory fitness and smoking-related and total cancer mortality in men. Med Sci Sports Exerc 34(5):735–739CrossRef Lee CD, Blair SN (2002) Cardiorespiratory fitness and smoking-related and total cancer mortality in men. Med Sci Sports Exerc 34(5):735–739CrossRef
19.
go back to reference American College of Sports Medicine (2014) ACSM’s guidelines for exercise testing and prescription, 9th edn. Wolters Kluwer/Lippincott Williams & Wilkins Health, Philadelphia American College of Sports Medicine (2014) ACSM’s guidelines for exercise testing and prescription, 9th edn. Wolters Kluwer/Lippincott Williams & Wilkins Health, Philadelphia
20.
go back to reference Fletcher GF, Ades PA, Kligfield P, Arena R, Balady GJ, Bittner VA, Coke LA, Fleg JL, Forman DE, Gerber TC, Gulati M, Madan K, Rhodes J, Thompson PD, Williams MA, American Heart Association Exercise CR, Prevention Committee of the Council on Clinical Cardiology CoNPA, Metabolism CoC, Stroke N, Council on E, Prevention (2013) Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation 128(8):873–934. https://doi.org/10.1161/CIR.0b013e31829b5b44 CrossRefPubMed Fletcher GF, Ades PA, Kligfield P, Arena R, Balady GJ, Bittner VA, Coke LA, Fleg JL, Forman DE, Gerber TC, Gulati M, Madan K, Rhodes J, Thompson PD, Williams MA, American Heart Association Exercise CR, Prevention Committee of the Council on Clinical Cardiology CoNPA, Metabolism CoC, Stroke N, Council on E, Prevention (2013) Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation 128(8):873–934. https://​doi.​org/​10.​1161/​CIR.​0b013e31829b5b44​ CrossRefPubMed
21.
go back to reference Page WF, Mahan CM, Kang HK (1996) Vital status ascertainment through the files of the Department of Veterans Affairs and the Social Security Administration. Ann Epidemiol 6(2):102–109CrossRef Page WF, Mahan CM, Kang HK (1996) Vital status ascertainment through the files of the Department of Veterans Affairs and the Social Security Administration. Ann Epidemiol 6(2):102–109CrossRef
22.
go back to reference Dominitz JA, Maynard C, Boyko EJ (2001) Assessment of vital status in Department of Veterans Affairs national databases. Comparison with state death certificates. Ann Epidemiol 11(5):286–291CrossRef Dominitz JA, Maynard C, Boyko EJ (2001) Assessment of vital status in Department of Veterans Affairs national databases. Comparison with state death certificates. Ann Epidemiol 11(5):286–291CrossRef
26.
go back to reference World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective
27.
go back to reference Schuz J, Espina C, Villain P, Herrero R, Leon ME, Minozzi S, Romieu I, Segnan N, Wardle J, Wiseman M, Belardelli F, Bettcher D, Cavalli F, Galea G, Lenoir G, Martin-Moreno JM, Nicula FA, Olsen JH, Patnick J, Primic-Zakelj M, Puska P, van Leeuwen FE, Wiestler O, Zatonski W, Working Groups of Scientific E (2015) European code against cancer 4th edition: 12 ways to reduce your cancer risk. Cancer Epidemiol 39(Suppl 1):S1–10. https://doi.org/10.1016/j.canep.2015.05.009 CrossRefPubMed Schuz J, Espina C, Villain P, Herrero R, Leon ME, Minozzi S, Romieu I, Segnan N, Wardle J, Wiseman M, Belardelli F, Bettcher D, Cavalli F, Galea G, Lenoir G, Martin-Moreno JM, Nicula FA, Olsen JH, Patnick J, Primic-Zakelj M, Puska P, van Leeuwen FE, Wiestler O, Zatonski W, Working Groups of Scientific E (2015) European code against cancer 4th edition: 12 ways to reduce your cancer risk. Cancer Epidemiol 39(Suppl 1):S1–10. https://​doi.​org/​10.​1016/​j.​canep.​2015.​05.​009 CrossRefPubMed
28.
go back to reference Mukaka MM (2012) Statistics corner: a guide to appropriate use of correlation coefficient in medical research. Malawi Med J 24(3):69–71PubMedPubMedCentral Mukaka MM (2012) Statistics corner: a guide to appropriate use of correlation coefficient in medical research. Malawi Med J 24(3):69–71PubMedPubMedCentral
32.
go back to reference Farrell PA, Joyner MJ, Caiozzo VJ (2012) ACSM’s advanced exercise physiology, 2nd edn. Lippncott Williams & Wilkins, Baltimore Farrell PA, Joyner MJ, Caiozzo VJ (2012) ACSM’s advanced exercise physiology, 2nd edn. Lippncott Williams & Wilkins, Baltimore
Metadata
Title
The preventive role of cardiorespiratory fitness in current male smokers who meet the American Cancer Society criteria for lung cancer screening: a prospective pilot study
Authors
Baruch Vainshelboim
Jonathan Myers
Publication date
01-02-2020
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 2/2020
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-019-01262-3

Other articles of this Issue 2/2020

Cancer Causes & Control 2/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine